Article By:
ChinaBio® Today
Saturday, March 23, 2024 2:00 PM EDT
Shanghai WuXi Biologics has broken ground on a $1.4 billion facility in Singapore. Meanwhile, Novo Nordisk announced plans to invest $556 million to expand its Tianjin city production facility.
OncoSec Raising Its Profile In Fight Against Cancer
I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.
OncoSec Raising Its Profile In Fight Against Cancer
Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK
OncoSec Raising Its Profile In Fight Against Cancer
Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY